REGULAR ARTICLE| Volume 104, ISSUE 4, P257-264, November 15, 2001

A New Factor X Defect (Factor X Padua 3)

A Compound Heterozygous Between True Deficiency (Gly380→Arg) and an Abnormality (Ser334→Pro)


      We report a novel mutation in Factor X (FX) gene which results in a phenotype without any bleeding tendency. The proband has been found to be a compound heterozygote between a novel FX true deficiency (Gly380→Arg) and a previously reported dysfunctional mutation Ser334→Pro (FX Marsiglia). Prothrombin time (PT) and partial thromboplastin time (PTT) were moderately prolonged and were fully corrected by the addition of normal serum. Her FX activity level varied between 8% and 19% of normal according to the method used whereas the FX antigen level was 40% of the normal control value. All the exons and intron/exon junctions of the FX gene were studied using a combined approach of polymerase chain reaction and conformation sensitive gel electrophoresis. A transversion G to A in exon 8 resulting in the replacement of Gly380 by Arg was found in the proband, in the father and in a proband's brother, whereas heterozygous FX Marsiglia was present in the proband's mother and her sister. Gly380 is strictly linked to Ser379, a component of the catalytic triad. The substitution of Gly for Arg causes the introduction of a large charged amino acid which could affect the catalytic function of FX leading to secretion problem, accounting for the cross-reactive material (CRM) negative phenotype.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Thrombosis Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • James HL
        Physiology and biochemistry of factor X.
        in: Bloom AL Forbes CD Thomas DP Tuddenham EGD Haemostasis and thrombosis. Livingstone, Edinburgh1994: 439-464
        • Leytus SP
        • Chung DW
        • Kisiel W
        • Kurachi K
        • Davie EW
        Characterization of a cDNA coding for human factor X.
        Proc Natl Acad Sci USA. 1984; 81: 3699-3702
        • Fair DS
        • Edgington TS
        Heterogeneity of hereditary and acquired factor X deficiency by combined immunochemical and functional analyses.
        Br J Haematol. 1985; 59: 235-248
        • Perry D
        Factor X and its deficiency states.
        Haemophilia. 1997; 3: 159-172
        • Hougie C
        • Barrow HM
        • Graham JB
        Stuart clotting defect. Segregation of a hereditary hemorrhagic state from the heterozygous heretofore called “stable factor” (SPCA, proconvertin factor VII deficiency).
        J Clin Invest. 1957; 36: 485-493
        • Cooper DN
        • Millar DS
        • Wacey A
        • Pemberton S
        • Tuddenham EGD
        Inherited factor X deficiency: molecular genetics and patho-physiology.
        Thromb Haemostasis. 1997; 78: 161-172
        • Girolami A
        Tentative and updated classification of factor X variants.
        Acta Haematol. 1986; 75: 58-59
        • Aurell L
        • Friberger P
        • Karlsson G
        • Cleason G
        A new sensitive and highly specific chromogenic peptide substrate for factor Xa.
        Thromb Res. 1977; 11: 595-605
        • Girolami A
        • Molaro G
        • Lazzarin M
        • Scarpa R
        • Brunetti A
        A ‘new’ congenital haemorrhagic condition due to the presence of an abnormal factor X (factor X Friuli): study of a large kindred.
        Br J Haematol. 1970; 19: 179-192
        • Simioni P
        • Vianello F
        • Kalafatis M
        • Barzon L
        • Ladogana S
        • Paolucci P
        • Carotenuto M
        • Dal Bello F
        • Palu G
        • Girolami A
        A dysfunctional factor X (factor X San Giovanni Rotondo) present at homozygous and double heterozygous level: identification of a novel microdeletion (delC556) and missense mutation (Lys(408)→Asn) in the factor X gene. A study of an Italian family.
        Thromb Res. 2001; 101: 219-230
        • Girolami A
        • Lazzarin M
        • Scarpa R
        • Brunetti A
        Further studies on the abnormal factor X (factor X Friuli) coagulation disorder: a report of another family.
        Blood. 1971; 37: 534-541
        • Girolami A
        • Lazzarin M
        • Procidano M
        • Luzzatto G
        A family with heterozygous factor X Friuli defect outside Friuli.
        Blut. 1983; 46: 149-154
        • Girolami A
        • Vicarioto M
        • Ruzza G
        • Cappellato G
        • Vergolani A
        Factor X Padua: a ‘new’ congenital factor X abnormality with a defect only in the extrinsic system.
        Acta Haematol. 1985; 73: 31-36
        • Laemmli UK
        Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
        Nature. 1970; 227: 680-685
        • Towbin H
        • Staehelin T
        • Gordon J
        Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
        Proc Natl Acad Sci USA. 1979; 76: 4350-4354
        • James HL
        • Girolami A
        • Fair DS
        Molecular defect in coagulation factor X Friuli results from a substitution of serine for proline at position 343.
        Blood. 1991; 77: 317-323
        • Williams IJ
        • Abuzenadah A
        • Winship PR
        • Preston FE
        • Dolan G
        • Wright J
        • Peake IR
        • Goodeve AC
        Precise carrier diagnosis in families with haemophilia A: use of conformation sensitive gel electrophoresis for mutation screening and polymorphism analysis.
        Thromb Haemostasis. 1998; 79: 723-726
        • Padmanabhan K
        • Padmanabhan KP
        • Tulinsky A
        • Park CH
        • Bode W
        • Huber R
        • Blankenship DT
        • Cardin AD
        • Kisiel W
        Structure of human des(1–45) factor Xa at 2.2 A resolution.
        J Mol Biol. 1993; 232: 947-966
        • Guex N
        • Peitsch MC
        SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling.
        Electrophoresis. 1997; 18: 14-23
        • Bezeaud A
        • Miyata T
        • Zheng YZ
        • Kato H
        • Aillaud MF
        • Juhan Vague I
        • Guillin MC
        Functional consequences of Ser 334 to Pro mutation in a factor X variant (factor X Marseille).
        Thromb Haemostasis. 1993; 69 (Abstract): 617
        • Bernardi F
        • Castaman G
        • Redaelli R
        • Pinotti M
        • Lunghi B
        • Rodeghiero F
        • Marchetti G
        Topologically equivalent mutations causing dysfunctional coagulation factors VII (294Ala→Val) and X (334Ser→Pro).
        Hum Mol Genet. 1994; 3: 1175-1177